Top US health officials believe that Pfizer Inc's Covid-19 vaccine could be authorised for children aged 5-11 years old by the end of October, two sources familiar with the situation said on Friday 10 September 2021.
The timeline is based on the expectation that Pfizer, which developed the shot with Germany's BioNTech, will have enough data from clinical trials to seek emergency use authorisation (EUA) for that age group from the US Food and Drug Administration (FDA) towards the end of this month, the sources said.
They anticipate the FDA could make a decision on whether the shot is safe and effective in younger children within three weeks of the EUA submission.
The decision on whether to authorise a vaccine for younger children is eagerly anticipated by millions of Americans, particularly parents whose children started school in recent weeks amid a wave of infections driven by the Delta variant.
Source: www.news24.com
No comments:
Post a Comment